Jci_page_head_homepage_01 Jci_page_head_homepage_02
Edward J. Weinman, Rajat S. Biswas, Quihong Peng, Lily Shen, Christina L. Turner, Xiaofei E, Deborah Steplock, Shirish Shenolikar, Rochelle Cunningham
Published in Volume 117, Issue 11
J Clin Invest. 2007; 117(11):3412–3420 doi:10.1172/JCI32738
Abstract | Full text | PDF
Options: View larger image (or click on image)
Medium
Figure 9
Representative immunoblots using an anti–NHERF-1 antibody of whole cell lysates (WH) and BBM fractions of BSC-1 cells transfected with His-tagged wild-type NHERF-1, His-NHERF-1 with a 30-aa C-terminal truncation (ΔERM), His-NHERF-1 with the PDZ II sequence PNGYGF mutated to HNGAGA (PDZ II mutant), or His-NHERF-1 with the PDZ I sequence HNGYGF mutated to PNGAGA (PDZ I mutant).

Nontransfected cells are shown in the first 2 lanes. The results shown were obtained in transiently transfected cells, although identical results were obtained in stably transfected cells (see Results).